title: Severe cholinergic urticaria successfully treated with scopolamine butylbromide in addition to antihistamines.
authors.forename: H
authors.initials: H
authors.lastname: Ujiie
authors.forename: T
authors.initials: T
authors.lastname: Shimizu
authors.forename: K
authors.initials: K
authors.lastname: Natsuga
authors.forename: K
authors.initials: K
authors.lastname: Arita
authors.forename: K
authors.initials: K
authors.lastname: Tomizawa
authors.forename: H
authors.initials: H
authors.lastname: Shimizu
mesh_terms: D000328:Adult; D002086:Butylscopolammonium Bromide / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015444:Exercise; D015738:Famotidine / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006358:Hot Temperature / Q000009:adverse effects; D006801:Humans; D006919:Hydroxyzine / Q000627:therapeutic use; D008297:Male; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use; D014581:Urticaria / Q000188:drug therapy* / Q000209:etiology
chemical_list: D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D018727:Muscarinic Antagonists; D010879:Piperazines; D002086:Butylscopolammonium Bromide; D006919:Hydroxyzine; D015738:Famotidine; C015408:oxatomide